RACHEL BROUSSEAU: Open Payments
NPI 1609374503 · SAUGERTIES, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,630 in 102 payments from 27 companies in 2025. Trend: 2023 $0 · 2024 $575 · 2025 $1,630
Food & beverage: $1,630
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $193 |
| GlaxoSmithKline, LLC. | 16 | $189 |
| PFIZER INC. | 14 | $183 |
| Exact Sciences Corporation | 4 | $99 |
| Lundbeck LLC | 4 | $93 |
| Amgen Inc. | 5 | $81 |
| ABBVIE INC. | 2 | $68 |
| Sumitomo Pharma America, Inc. | 3 | $61 |
| Aimmune Therapeutics, Inc. | 3 | $56 |
| Lilly USA, LLC | 3 | $51 |
Products named: ELIQUIS, REXULTI, TRELEGY ELLIPTA, The Cologuard Plus Collection Kit, Ozempic, QULIPTA, EVENITY, GEMTESA.
Industry payments across NY — which companies pay providers there.
